MUSC-Hollings Cancer Center — Charleston, South Carolina

MUSC-Hollings Cancer Center is a clinical research site located in Charleston, South Carolina, United States 29425.

Crixeo Clinical Trials Trust Score: 25/100 (FAILING). This profile has not yet been claimed by the site owner.

MUSC-Hollings Cancer Center has participated in 41 clinical trials with 13 currently active.

Therapeutic areas: Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Non-Hodgkin Lymphoma, Soft Tissue Sarcoma.

Sponsors: Pfizer, Novartis Pharmaceuticals, Threshold Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Charleston

Browse all research sites in South Carolina · View every site in Charleston

• Duplicate_Medical University of South Carolina /ID# 228067
• Ralph H. Johnson Department of Veterans Affairs Medical Center
• Duplicate_Medical University of South Carolina /ID# 221072
• Medical University of South Carolina (MUSC) - Hollings Cancer Center
• Medical University of South Carolina /ID# 265113
• Medical University of South Carolina Weight Management Center
• Medical University South Carolina Hospitals and Clinics
• Medical University of South Carolina Children Hospital - PIN
• Medical University of South Carolina Hematology-Oncology Division
• Addiction Sciences Division-Medical University of South Carolina
• Medical University of South Carolina Infectious Disease Clinic
• Medical University of South Carolina (MUSC) - College of Medicine (COM)

Sponsor Feasibility Report

Trust Score: 25/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for MUSC-Hollings Cancer Center?

MUSC-Hollings Cancer Center has a Crixeo Trust Score of 25/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has MUSC-Hollings Cancer Center conducted?

MUSC-Hollings Cancer Center has 41 clinical trials on record, with 13 currently active. Their work covers Leukemia, Myelogenous, Chronic, Breakpoint Cluster Region-Abelson Proto-oncogene (BCR-ABL) Positive, Non-Hodgkin Lymphoma, Soft Tissue Sarcoma.

Is MUSC-Hollings Cancer Center accredited by Crixeo Clinical Trials?

MUSC-Hollings Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about MUSC-Hollings Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.